Malignant Mixed Mesodermal Ovarian Tumor Treatment and Prognosis: A 20-Year Experience

This publication has 10 references indexed in Scilit:

• Malignant mixed mesodermal tumors of the ovary
  Published by Wolters Kluwer Health ,2000
• Mesna, Doxorubicin, Ifosfamide, and Dacarbazine Chemotherapy for Ovarian Mixed Müllerian Sarcoma: Report of Four Cases
  Gynecologic Oncology, 1995
• A Phase II Trial of Ifosfamide and Mesna in Patients with Advanced or Recurrent Mixed Mesodermal Tumors of the Ovary Previously Treated with Platinum-Based Chemotherapy: A Gynecologic Oncology Group Study
  Gynecologic Oncology, 1994
• Prospective Trial of Cisplatin, Adriamycin, and Dacarbazine in Metastatic Mixed Mesodermal Sarcomas of the Uterus and Ovary
  American Journal of Clinical Oncology, 1991
• Complete response of carcinosarcoma of the ovary to therapy with doxorubicin, ifosfamide, and dacarbazine
  Gynecologic Oncology, 1991
• Clinicopathologic features of ovarian mixed mesodermal tumors and carcinosarcomas
  Gynecologic Oncology, 1989
• Five-year survival following combination radiotherapy and chemotherapy for recurrent mixed mesodermal sarcoma of the ovary
  Gynecologic Oncology, 1985
• A clinical and pathologic study of 30 cases of malignant mixed mullerian epithelial and mesenchymal ovarian tumors: A gynecologic oncology group study
  Gynecologic Oncology, 1984
• Malignant Mixed Mesodermal Tumors and Carcinosarcoma of the Ovary
  Obstetrical & Gynecological Survey, 1983
• Chemotherapy in management of mixed mesodermal tumors of the ovary
  Gynecologic Oncology, 1980